References

Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D et al. (1996) Role of ploidy, chromosome ip, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 334:1505-1511

Ambros IM, Attarbaschi A, Rumpler S, Luegmayr A, Turkof E, Gadner H, Ambros PF (2001) Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med Pediatr Oncol 36:163-168

Ambros IM, Hata J-I, Joshi VV, Roald B, Dehner LP, Tuchler H, Potschger U, Shimada H (2002) Morphologic features of neuroblastoma (Schwannian stroma poor tumors) in clinically favorable and unfavorable groups. Cancer 94:15741583

Beckwith JB, Martin RF (1968) Observations on the histo-pathology of neuroblastomas. J Pediatr Surg 3:106-110

Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams and Wilkins, Philadelphia, pp 895-938

Bursch W, Liehr JG, Sirbasku DA, Putz B, Taper H, Schulte-Her-mann R (1991) Control of cell death (apoptosis) by diethyl-stilbestrol in an estrogen-dependent kidney tumor. Car-cinogenesis 12:855-860

Dehner LP (1988) Classic neuroblastoma: histopathologic grading as a prognostic indicator: the Shimada system and its progenitors. Am J Pediatr Hematol Oncol 10:143-154

Goto S, Umehara S, Gebing RB, Stram DO, Brodeur GM, Seeger RC et al. (2001) Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. A report from the Children's Cancer Group. Cancer 92:2699-2708

Gross RE, Farber S, Martin LW (1959) Neuroblastoma sympa-theticum, a study and report of 217 cases. Pediatrics 23:11791191

Hughes M, Marsden HB, Palmer MK (1974) Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34:1706-1711 Joshi VV, Cantor AB, Altshuler A, Larkin EW, Neill JSA, Shuster JJ et al. (1992) Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: a clinical pathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69:2197-2211 Joshi VV, Rao PV, Canter AB, Altshuler G, Shuster JJ, Castleber-ry RP (1996) Modified histologic grading of neuroblastoma by replacement of mitotic rate with mitosis karyprrhexis index: a clinicopathologic study of 223 cases from the Pediatric Oncology Group. Cancer 77:1582-1588 Landau M (1911) Verhandlungen des Internationalen Pathologischen Kongresses, Turin Mäkinen J (1972) Microscopic patterns as guide to prognosis of neuroblastoma in childhood. Cancer 29:1637-1646 Mora J, Cheung NK, Juan G, Illei P, Cheung I, Akram M, Chi S, Ladanyi M, Cordon-Cardo C, Gerald WL (2001) Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res 61:6892-6898 Peuchmaur M, d'Amore ESG, Joshi VV, Hata J, Roald B, Dehner LP et al. (2003) Revision of the International Neuroblas-toma Pathology Classification: Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblas-toma, nodular. Cancer 98:2274-2281 Reynolds ML, Woolf CJ (1993) Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 3:683-693 Ross JA, Severson RK, Pollock BH, Robison LL (1996) Childhood cancer in the United States.A geographical analysis of cases from the Pediatric Cooperative Clinical Trial groups. Cancer 77:201-207 Schmidt ML, Salwen HR, Chagnovich D, Bauer KD, Crawford SE, Cohn SL (1993) Evidence for molecular heterogeneity in human ganglioneuroblastoma. Pediatr Pathol 13:787-796 Shimada H, Chatten J,Newton WA, Sachs N, Hamoudi AB, Chiba T et al. (1984) Histopathologic prognostic factors in neuroblastic tumors; definition of subtypes of ganglioneuro-blastoma and an age-linked classification of neuroblas-tomas. J Natl Cancer Inst 73:405-416 Shimada H, Aoyama C, Chiba T, Newton WA Jr (1985) Prognostic subgroups for undifferentiated neuroblastoma: im-munohistochemical study with anti-S-100 protein antibody. Hum Pathol 16:471-476 Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999a) Terminology and morphologic criteria of neuroblastic tumors: recommendation by the International Neuroblastoma Pathology Committee. Cancer 86:349-363 Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B et al. (1999b) The International Neuroblastoma Pathology Classification (Shimada System). Cancer 86:364-372 Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM et al. (1995) Identification of subsets of neu-roblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 87:1470-1476

Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S et al. (2001) International Neuroblastoma Pathology Classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92:2451-2461 Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN et al. (2004) TrkA expression in peripheral neu-roblastic tumors: prognostic significance and biological relevance. Cancer 101:1873-1881

Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO et al. (2000) Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular: a report from the Children's Cancer Group. Cancer 89:1150-1161 Wahl HR (1914) Neuroblastomata; with a study of a case illustrating the three types that arise from the sympathetic system. J Med Res 30:205-260

Molecular Pathology of Neuroblastic Tumors Based on Genome-wide Expression Analysis

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment